Home -> Law Blog Directory -> Qui Tam Blogs -> Pharma 101 - Pharmaceutical Fraud

Qui Tam

: Pharma 101 - Pharmaceutical Fraud

Drug Company Settles Adulterated Drug Case, Highlighting Need for Courageous Whistleblowers

By Nolan and Auerbach

Recently, the United States Department of Justice announced the settlement of the first False Claims Act qui tam case predicated on current Good Manufacturing Practice (cGMP) violations. In this settlement, GlaxoSmithKline pled guilty and agreed to pay $750 million to resolve criminal and civil liability regarding manufacturing deficiencies at its Puerto Rico plant. According to the government, the company?s manufacturing operations failed to ensure that its drugs were free of contamination from read more

Full post as published by Pharma 101 - Pharmaceutical Fraud on November 19, 2010 (boomark / email).